Clinsys Clinical Research, BioReliance Corporation, InVentiv
Health, PRA International, Kendle, Parexel, PPD, Wyeth and
PharmaNet have all had people on the move in the world of
pharmaceutical outsourcing.
Outsourced pharmaceutical R&D spending is set to increase
at twice the expected rate of general R&D expenditure
for the next five years, according to new research published this
week.
US-based firm Goodwin Biotechnology said it is about to complete
the expansion of its biomanufacturing facility as the number of
contracts with biotech companies has jumped in the past two years.
In this week's review of activity within the preclinical research
services arena, new deals have emerged involving Gene Bridges,
Panacos Pharmaceuticals, and GenScript.
Kendle has climbed back into the black in the first quarter of 2007
after another quarter of strong sales although pre-tax profit
remains down on 2006.
The pharma industry sees great opportunities in using Radio
Frequency Identification (RFID) technology during clinical trials,
a new survey has revealed.
Clinical trial sponsors are outsourcing the majority of clinical
work in Phase I and gradually bringing functions back in-house as
compounds move through the development stages.
Parexel has announced healthy financial results for its third
fiscal quarter, despite another disappointing performance in its
medical communications business.
Contract research organisation (CRO) Chiltern has announced it is
expanding its services with a new solution aimed at helping clients
boost their clinical research staff recruitment process - an
increasingly difficult task due to...
Clinical trials are saving lives but may be killing the environment
due to their 'intensive energy use' and 'substantial
contribution to greenhouse gasses.'
Most clinical trial sites are utterly unprepared in the face of a
natural disaster and are paying a heavy price if they are unlucky
enough to be affected, delegates heard at last week's Drug
Information Association (DIA) conference...
Insurance firm Darwin is targeting the booming contract research
organisation (CRO) market by launching its own insurance cover
designed specifically for companies or organisations involved in
clinical research.
INC Research has become the latest contract research organisation
(CRO) to dive into India, whilst Pharmaceutical Products
Development (PPD) has opened offices in Athens and Seattle.
Japan is getting serious about clinical trial reform after years of
lagging behind the rest of the developed world in the availability
of drugs in the country, which ironically is the world's number two
pharma market behind the...
Indian contract research organisation (CRO) Synchron has acquired
local start-up CRO Innovance - a first-of-its-kind buyout in this
booming area of the pharma market.
Medifacts International has sold its contract research organisation
(CRO) unit after a reorganisation sparked by the firm's filing for
Chapter 11 bankruptcy protection in February.
Covance is seeing the high potential of the booming market for
biomarkers and has decided to devote an entire expert team to
support clients with biomarker-related services.
The pan-European drug regulator, the European Medicines Agency
(EMEA), has adopted a draft guideline for first-in-man clinical
studies for potential high-risk drugs in a bid to prevent a repeat
of last year's TGN1412 drug trial...
The purchase of Canada's Allied Research International (ARI) has
given Cetero Research a boost to its early-phase clinical services
and geographic reach in Canada.
PharmaNet has been told by the US Securities and Exchange
Commission (SEC) that it will now be the subject of a formal
investigation as it continues to be haunted by the early phase unit
it used to own in Miami.
Legal action could begin today against Parexel if the firm does not
come up with "an adequate proposal" to compensate the victims of
last years drug trial disaster in Northwick Park, London.
PDL BioPharma, Synexus, Kendle, PharmaNet Development Group, MDS,
Chiltern International and Laureate Pharma have all had people on
the move in the world of pharmaceutical outsourcing.
India's budget finance minister has today announced a tax exemption
on all services carried out by its contract research and clinical
trials industry – a saving of 12.24 per cent.
Hesperion has opened a Russian arm of its contract research
business in a bid to 'increase its attractiveness' to clinical
trial sponsors requiring large patient populations.
Parexel has announced encouraging financial results for its second
fiscal quarter, despite 'disappointing' performance in its medical
communications business.
PRA International has entered into an alliance with US Oncology
Research, designed to accelerate the clinical development of new
cancer treatments in the US.
UK biotech company Verona Pharma has contracted fellow UK firm Onyx
to manufacture supplies of its new hay fever drug candidate for
forthcoming preclinical and clinical studies.
Charles River Laboratories confirmed it is persevering in its
intention to focus on its preclinical and Phase I businesses while
abandoning its late stage development services, during a conference
earlier this month.
Canadian contract manufacturer QSV Biologics has signed two
manufacturing deals in as many weeks, strengthening its position in
the Phase II and III clinical supplies arena.
There are currently three key market trends that play to Parexel's
strengths and one of them is the globalisation of clinical trials,
the company's CEO claimed during a healthcare conference earlier
this month.
Covance was nothing but optimistic about the future of contract
research organisations (CROs) during a JPMorgan healthcare
conference held last week, despite a slowdown in R&D spending
over the past year.
A new study condemns the high prevalence of ghost writing in
pharmaceutical company-sponsored clinical trials and calls for the
controversial practice to be culled in order to improve
transparency.
Quintiles has teamed up with practices group Onmark to create a
national clinical trial network comprised of Onmark members - a
move that could help the CRO cope with increasing patient
recruitment issues in the US.
China is now an industry buzzword when it comes to outsourcing and
yet another report adds to the list of research recently published
that give evidence of the increasing popularity of the country as a
location to conduct drug clinical...
Singapore is planning to double the number of clinical trials it
runs over the next five year, particularly in early phase research,
as it looks to hold its ground amidst industry explosion in the
Asia Pacific.
The booming pharmaceutical contract research market sees a new
player enter the arena as analytical lab Eno River Labs separates
into two independent divisions to create a new business that will
provide analytical and formulation...
Helix BioPharma and BioVectra have signed a deal for the
manufacture of Helix's new lung cancer drug for clinical trials - a
move that strengthens the already existing relationship between the
two Canadian firms.
Despite the many challenges facing the pharma industry, drug
developers should be optimistic, and one of the reasons is the
increasing reliance on global outsourcing to speed development and
reduce costs, says new report.
It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...
The use of internal standards (IS) is essential for developing and applying liquid chromatography-tandem mass spectrometric (LC-MS/MS) quantitative bioanalytical...
A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...
